Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Plasma concentrations of phyto-oestrogens in Japanese men.

Adlercreutz H, Markkanen H, Watanabe S.

Lancet. 1993 Nov 13;342(8881):1209-10.

PMID:
7901532
2.

Phytoestrogen concentrations in serum from Japanese men and women over forty years of age.

Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA.

J Nutr. 2002 Oct;132(10):3168-71.

3.

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.

Hedlund TE, Johannes WU, Miller GJ.

Prostate. 2003 Jan 1;54(1):68-78.

PMID:
12481257
4.

Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay.

Uehar M, Arai Y, Watanabe S, Adlercreutz H.

Biofactors. 2000;12(1-4):217-25.

PMID:
11216489
5.

Exposure of infants to phyto-oestrogens from soy-based infant formula.

Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE.

Lancet. 1997 Jul 5;350(9070):23-7.

PMID:
9217716
7.

Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom.

Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Lloyd S, Griffiths K.

Prostate. 1997 Jul 1;32(2):122-8.

PMID:
9215400
8.

Case-control study of phyto-oestrogens and breast cancer.

Ingram D, Sanders K, Kolybaba M, Lopez D.

Lancet. 1997 Oct 4;350(9083):990-4.

PMID:
9329514
9.

Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet.

Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T, Okada H.

Am J Clin Nutr. 1991 Dec;54(6):1093-100.

PMID:
1659780
10.

Determination of lignans and isoflavonoids in human female plasma following dietary supplementation.

Morton MS, Wilcox G, Wahlqvist ML, Griffiths K.

J Endocrinol. 1994 Aug;142(2):251-9.

PMID:
7930998
11.
12.
13.

Maternal and neonatal phytoestrogens in Japanese women during birth.

Adlercreutz H, Yamada T, Wähälä K, Watanabe S.

Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):737-43.

PMID:
10076156
14.

Phyto-oestrogens and cardiovascular disease risk.

van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE.

Nutr Metab Cardiovasc Dis. 2000 Jun;10(3):154-67. Review.

PMID:
11006924
15.

Phyto-oestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older men.

Heald CL, Bolton-Smith C, Ritchie MR, Morton MS, Alexander FE.

Eur J Clin Nutr. 2006 Jan;60(1):129-35.

PMID:
16205743
16.
17.

Phyto-oestrogens and risk of prostate cancer in Scottish men.

Heald CL, Ritchie MR, Bolton-Smith C, Morton MS, Alexander FE.

Br J Nutr. 2007 Aug;98(2):388-96. Epub 2007 Apr 3.

PMID:
17403269
18.

Urinary excretion of isoflavonoids and the risk of breast cancer.

Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):35-40.

19.

Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.

Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS.

Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):581-6.

20.

Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.

Tanaka M, Fujimoto K, Chihara Y, Torimoto K, Yoneda T, Tanaka N, Hirayama A, Miyanaga N, Akaza H, Hirao Y.

Prostate Cancer Prostatic Dis. 2009;12(3):247-52. doi: 10.1038/pcan.2009.10. Epub 2009 Jul 14.

Supplemental Content

Support Center